15-09-2026 06:53
via
smh.com.au
Amplia opens new front in ovarian cancer fight
Amplia Therapeutics has finalised plans for its PRROSE phase two ovarian cancer trial, with site activation and patient recruitment targeted before year-end.
Read more »
Analyst news
Opinion: Charting a course for convergence
Saffioti, Carey issue interest rate warning
‘Shocked’, Rita Saffioti on brick shortage update
Court dismisses ex-tomato king Michael Le’s proceedings against feds
Auric pockets bargain hardware to fast-track WA Burbanks plant
Emerald secures $US400m deal war chest from Sprott, Macquarie
Judge revs up Steve Wyatt on Chris Ellison action
Fortescue, state government appeal Yindjibarndi compensation verdict
Barkly jags rich rare earths across 23km in NT
Euroz directors endorse $145m BMO sale
The 31-year-old who might end up as the world’s most educated person
Key SA wave buoy to be redeployed a third time after lightning damage
Kenilworth Dairies offers lifeline to Queensland dairy farm facing closure
xAmplify expand to Perth with local acquisition
Desktop versie